Carrera Capital Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Sell
1,539,121
-202,714
-12% -$2.47M 2.54% 8
2026
Q1
$24.3M Buy
1,741,835
+1,246,995
+252% +$17.5M 3.75% 4
2025
Q4
$7.3M Buy
+494,840
New +$7.44M 1.23% 19

Other funds holding BTAL

Carrera Capital Advisors's BTAL Position: Q2 2026 in Review

Carrera Capital Advisors reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 12% in Q2 2026, selling an estimated $2.47M and leaving 1,539,121 shares worth $17.2M. The position accounts for 2.54% of the portfolio, ranked #8.

Carrera Capital Advisors first reported a position in BTAL in Q4 2025 and has held it in 3 quarters since. The position peaked at $24.3M in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Carrera Capital Advisors held 1,539,121 shares of AGF US Market Neutral Anti-Beta Fund worth $17.2M as of Q2 2026.
  • Carrera Capital Advisors sold 202,714 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $2.47M.
  • AGF US Market Neutral Anti-Beta Fund made up 2.54% of Carrera Capital Advisors's portfolio in Q2 2026, its #8 holding.
  • Carrera Capital Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2025 and has held it in 3 quarters since.
  • Carrera Capital Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $24.3M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Carrera Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.